DYN NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Dyne Therapeutics Inc · Healthcare · Biotechnology

Open interactive chart View report data
Latest close 24.44 USD
2.9% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 32.1% above the Trend Line and sits at 96.5% of its 52-week range. The latest completed week returned 2.9%, after a 16.7% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 47/100 conviction, while the latest news-sentiment score is 56/100. Near-term considerations: price is close to its 52-week high.

Setup score 76 out of 100
Latest Close 24.44 USD 24 Jul 2026
1W Return 2.9% latest completed week
4W Return 16.7% short-term follow-through
12W Return 40.5% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 2.3x vs 13-week average
What is working
  • The trend backdrop is active with a 5-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • No major top-level risk cluster is currently dominant.
What to watch next
  • Price is close to its 52-week high; watch for continuation or exhaustion.
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 2.9% Latest completed week; four-week move 16.7%. Indicator stack 47/97 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 47/100 conviction; expected move 24.0%. News sentiment 56/100 55 relevant articles in the latest sentiment read. Event risk 27 Jul Latest stored earnings date was 27 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 32.1% above the Trend Line and sits at 96.5% of its 52-week range. The latest completed week returned 2.9%, after a 16.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 2.3x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6012-week average 0.42

12-week confirmation

Trend active5/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure11/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership7/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.60Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 16.7% over four weeks, 40.5% over 12 weeks, and 145.6% over one year. The current trend has remained active for 5 consecutive weeks.

Performance by holding period

1W2.9%
4W16.7%
12W40.5%
26W35.8%
52W145.6%
Active trend streak5 weeks
Active weeks in one year28
Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.72Latest activity-pressure read.
Pressure change197.2%Four-week change in activity pressure.
Leadership28.61Latest relative-leadership reading.
RS change136.6%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength64/100Blend of value, momentum, and quality. Underlying universe rank 37; rank 1 is best.
Value56/100Relative valuation strength. Underlying universe rank 45; rank 1 is best.
Quality55/100Profitability and accounting quality. Underlying universe rank 46; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth56/100Revenue and earnings growth. Underlying universe rank 45; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-12.8%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-248.2%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-14.7%
Net share repurchases relative to market value.
Shareholder yield
-14.7%
Dividend yield plus net buyback yield.
Net debt / EBITDA
1.7x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

DYN shows volatility options pressure with a 47/100 conviction score, put-call volume ratio of 0.67, expected move of 24.0%, and Sharemaestro trend signal active.

Conviction47/100
Expected move24.0%
Put/call volume0.67
Pressure8
Speculation42
Volatility96
Trend agreement96
Open options detail
Insider activity0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment56/100

Weighted news tone is neutral across 55 relevant articles.

18 positive · 30 neutral · 7 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings27 JulLatest stored earnings date was 27 Jul 2026.
Options expected move24.0%Nearest-chain priced movement where available.
52-week drawdown-2.2%Distance below the 52-week high.
13-week volatility6.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+20.6%Week of 13 Mar.
Worst week-11.8%Week of 5 Jun.
Latest week+2.9%Week of 24 Jul.

Shape of recent returns

Strong gains9
Modest gains5
Flat weeks0
Modest losses5
Sharp losses7
Recent vol6.1%13-week weekly-return volatility.
Base vol8.5%52-week weekly-return volatility.
Up/down split31/21Count of positive and negative weeks in the 52-week window.
Average skew7.2% / -5.5%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape71/100

Trend, activity pressure, participation, and risk combine to a 71/100 tape read.

 Indicator analysis60/100

Latest 12-week confirmation: trend 5/12, activity pressure 11/12, relative leadership 7/12.

Activity pressure 0.60; No reversal markers Factors57/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 89; Small Cap Core rank 50 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options61/100

DYN shows volatility options pressure with a 47/100 conviction score, put-call volume ratio of 0.67, expected move of 24.0%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 24.0% Sentiment56/100

Weighted news tone is neutral across 55 relevant articles.

Dyne Therapeutics Inc (DYN) Technical Analysis: Support, Resistance, Indicators & Moving Averages Insiders0 / 20

0 acquisitions and 20 disposals in the latest 180-day insider tape.

 Earnings27 Jul

Latest stored earnings date was 27 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202624.44 USD2.9%18.50 USD19.78 USD1.7228.6122.8MOn
17 Jul 202623.74 USD1.4%18.35 USD19.70 USD1.6224.498.5MOn
10 Jul 202623.42 USD1.5%18.22 USD19.62 USD1.4319.2111.9MOn
3 Jul 202623.07 USD10.2%18.09 USD19.54 USD1.0120.988.2MOn
26 Jun 202620.94 USD5.8%17.99 USD19.46 USD0.5812.0913.9MOn
19 Jun 202619.80 USD8.9%18.02 USD19.40 USD0.322.1211.3MOff
12 Jun 202618.19 USD6.7%18.07 USD19.34 USD0.13-3.177.9MOff
5 Jun 202617.04 USD-11.8%18.09 USD19.29 USD0.06-7.358.2MOff
29 May 202619.33 USD11.3%18.13 USD19.27 USD0.100.105.5MOff
22 May 202617.37 USD0.5%18.24 USD19.23 USD-0.01-7.248.4MOff
15 May 202617.29 USD-1.8%18.23 USD19.20 USD0.05-6.475.1MOff
8 May 202617.61 USD1.3%18.20 USD19.17 USD0.27-4.937.7MOff
1 May 202617.39 USD-4.8%18.09 USD19.15 USD0.28-0.867.6MOff
24 Apr 202618.26 USD-10.5%17.94 USD19.13 USD0.275.829.3MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.